Len Arzt, founder of the NAPT, describes the treatments journey and where it's going
Educational resources are evolving fast
Investing more than $200 million and adding 90 employees by 2026
Exposure gives cancer-capable cells 'a boost' over normal cells
Three-dimensional therapy is more successful than two-dimensional.
The vacancy rate of medical dosimetrists remains stable
In partnership with Swiss hospital, new model could be 'game changer'
Oversaw creation of the world's first proton treatment center
Had 6,500 phantoms installed worldwide
Will produce patient-specific boluses
The next frontier in improving cancer care
Publication aimed at helping patients make informed decisions.
Weighing appearance against disease recurrence risk
Patients may only need surgery and endocrine therapy
medPhoton is the developer of the Loop-X robot
